FDA Adverse Event Malfunction Summary report: N

D-DIMER

MDR report key: 4330089 · Received December 15, 2014

Report

Report Number
1823260-2014-09966
Event Type
Malfunction
Date Received
December 15, 2014
Date of Event
May 28, 2014
Report Date
January 27, 2015
Manufacturer
ROCHE DIAGNOSTICS
Product Code
GHH
PMA / PMN Number
K033491
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE CUSTOMER'S ANALYZER WAS PROVIDED FOR INVESTIGATION. RETENTION MATERIALS WERE TESTED ON THE CUSTOMER'S ANALYZER AND ALL MEASUREMENTS FULFILL REQUIREMENTS. TEST STRIPS FROM THE CUSTOMER SITE WERE REQUESTED FOR INVESTIGATION, BUT THESE COULD NOT BE PROVIDED.

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6).

Additional Manufacturer Narrative · 1

RETENTION MATERIALS WERE TESTED AND THE RESULTS OF ALL MEASUREMENTS FULFILL REQUIREMENTS.

Description of Event or Problem · 1

THE CUSTOMER HAS REPORTED THAT THEY HAVE RECEIVED QUESTIONABLE RESULTS FOR A TOTAL OF FOUR PATIENTS TESTED FOR ROCHE CARDIAC D-DIMER (DDI) ON A COBAS H232 METER WHEN COMPARED TO THE D-DIMER METHOD ON A SIEMENS CA 1500 INSTRUMENT. OF THE FOUR PATIENTS, TWO HAD RESULTS THAT WERE ERRONEOUS. THE FIRST PATIENT HAD A SAMPLE TESTED FOR DDI AND IT RESULTED AS 0.41 UG/ML ON (B)(6) 2014. THE FIRST PATIENT ALSO HAD ANOTHER SAMPLE TESTED ON THE SIEMENS CA 1500 INSTRUMENT AND IT RESULTED AS 1.3 MG/L FEU FOR D- DIMER ON (B)(6) 2014. THE SECOND PATIENT, A MALE BORN ON (B)(6) 1943, HAD A SAMPLE TESTED FOR DDI AND IT RESULTED AS 0.34 UG/ML ON (B)(6) 2014. THE SECOND PATIENT ALSO HAD ANOTHER SAMPLE TESTED ON THE SIEMENS CA 1500 INSTRUMENT AND IT RESULTED AS 0.8 MG/L FEU FOR D-DIMER ON (B)(6) 2014. THE PATIENTS WERE NOT ADVERSELY AFFECTED. THE SERIAL NUMBER OF THE COBAS H232 METER IS KS0206555. THIS METER IS NOT SOLD IN THE UNITED STATES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
820988 D-DIMER FIBRIN SPLIT PRODUCTS GHH ROCHE DIAGNOSTICS NA ASKU

Patients

Seq Age Sex Outcome Treatment
1 066 YR